Related references
Note: Only part of the references are listed.A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1
Kim B. Luley et al.
CANCERS (2020)
microRNA-221 Inhibits Latent TGF-β1 Activation through Targeting Thrombospondin-1 to Attenuate Kidney Failure-Induced Cardiac Fibrosis
Yue Zhou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation
Xi Tang et al.
CANCER LETTERS (2019)
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
Anna Kathrin Stueven et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
E. T. Aristizabal Prada et al.
ENDOCRINE CONNECTIONS (2018)
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
Tobias Hofving et al.
ENDOCRINE-RELATED CANCER (2018)
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
Daniel Benten et al.
MOLECULAR CANCER RESEARCH (2018)
MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases
Nadine Zimmermann et al.
Oncotarget (2018)
Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
Samantha Exner et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Fibroblast growth factor-2 and transforming growth factor-beta1 oppositely regulate miR-221 that targets thrombospondin-1 in bovine luteal endothelial cells
Svetlana Farberov et al.
BIOLOGY OF REPRODUCTION (2018)
Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors
Aura D. Herrera-Martinez et al.
ENDOCRINE (2018)
miR-221 targets HMGA2 to inhibit bleomycin-induced pulmonary fibrosis by regulating TGF-β1/Smad3-induced EMT
Yi-Chun Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1
Timon Vandamme et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
Anguraj Sadanandam et al.
CANCER DISCOVERY (2015)
miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases
Qinhong Xu et al.
ONCOTARGET (2015)
miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1
Jun Liu et al.
BMC UROLOGY (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2
Chang Zheng et al.
MEDICAL ONCOLOGY (2012)
The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
Su-Chen Li et al.
PLOS ONE (2012)
Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
Kjell E. Oberg et al.
GASTROENTEROLOGY (2010)
Inhibition of Phosphatidylinositol 3-Kinase/Akt Signaling Suppresses Tumor Cell Proliferation and Neuroendocrine Marker Expression in GI Carcinoid Tumors
Susan C. Pitt et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model
A. Scholz et al.
GUT (2009)
The effect of transforming growth factor on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling
Frank P. Leu et al.
MOLECULAR CANCER RESEARCH (2008)
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
Claudia Roldo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-β -: Evidence for oxidative signaling through NADPH oxidase
S Groth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)